In this Q&A article with the Eye Care Network, Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses the role of low- and ...
According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors. Although rare, semaglutide initiation can lead to ...
Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.
In the United States, aflibercept-yszy received Food and Drug Administration (FDA) approval in May 2024 as a biosimilar to ...
Ocular Therapeutix has released positive topline results from SOL-1, its phase 3 superiority trial of AXPAXLI for the ...
At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical ...
IOLs: What Every Surgeon Needs to Know is an editorially independent video and podcast series from Ophthalmology Times, ...
More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...
The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...
Age-related macular degeneration (AMD) is associated with aging and typified by a wide range of symptoms from vision ...
At Envision Summit 2026 in Puerto Rico, Inder Paul Singh, MD, discussed office-based surgery and the evolving concept of interventional glaucoma in a CE Spotlight Symposium with Mary Qiu, MD, and ...
Larissa Camejo, MD: I’m a glaucoma specialist and the owner of a solo private practice in Palm Beach Gardens, Florida. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results